{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:07Z","timestamp":1789430407024,"version":"build-2803163510"},"update-to":[{"DOI":"10.1016\/j.heliyon.2024.e35835","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000}}],"reference-count":129,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e35835","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T03:07:01Z","timestamp":1722913621000},"page":"e35835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["RETRACTED: Novel targets and improved immunotherapeutic techniques with an emphasis on antimycosal drug resistance for the treatment and management of mycosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Riya","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnendu","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arundhati","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnendu","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajit","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumpa","family":"Dhua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushik","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchandra","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6714-408X","authenticated-orcid":false,"given":"Rajkumar","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.heliyon.2024.e35835_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14787210.2020.1792288","article-title":"Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies","volume":"18","author":"Fernandes","year":"2020","journal-title":"Expert. Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/lam.12820","article-title":"Antifungals discovery: an insight into new strategies to combat antifungal resistance","volume":"66","author":"Fuentefria","year":"2017","journal-title":"Lett. Appl. Microbiol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35835_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib4","doi-asserted-by":"crossref","DOI":"10.2196\/11302","article-title":"Measurement of quality of life in patients with mycosis fungoides\/S\u00e9zary syndrome cutaneous T-cell lymphoma: development of an electronic instrument","volume":"21","author":"McCaffrey","year":"2019","journal-title":"J. Med. Internet Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35835_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35835_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00894-019-4221-2","article-title":"New inhibitors of homoserine dehydrogenase from Paracoccidioides brasiliensis presenting antifungal activity","volume":"25","author":"Bueno","year":"2019","journal-title":"J. Mol. Model."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35835_bib7","first-page":"336","article-title":"Antifungal therapy for systemic mycosis and the nanobiotechnology era: improving efficacy, biodistribution and toxicity","volume":"7","author":"Souza","year":"2017","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35835_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40257-020-00580-6","article-title":"The growing problem of antifungal resistance in onychomycosis and other superficial mycoses, the growing problem of antifungal resistance in onychomycosis and other superficial mycoses","volume":"22","author":"Gupta","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib9","article-title":"Fungal infections: pathogenesis, antifungals and alternate treatment approaches","volume":"3","author":"Reddy","year":"2022","journal-title":"Curr. Res. Microb. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35835_bib10","doi-asserted-by":"crossref","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","article-title":"Antifungal drug development: challenges, unmet clinical needs, and new approaches","volume":"4","author":"Roemer","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35835_bib11","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s00784-018-2625-5","article-title":"Survival percentages of atraumatic restorative treatment (ART) restorations and sealants in posterior teeth: an updated systematic review and meta-analysis","volume":"22","author":"de Amorim","year":"2018","journal-title":"Clin. Oral Invest."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s44259-023-00007-2","article-title":"Molecular mechanisms governing antifungal drug resistance","volume":"1","author":"Lee","year":"2023","journal-title":"NPJ Antimicrob. Resist."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/D1CB00154J","article-title":"Cyclic peptide drugs approved in the last two decades (2001\u20132021)","volume":"3","author":"Zhang","year":"2022","journal-title":"RSC. Chem. Biol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35835_bib15","doi-asserted-by":"crossref","first-page":"800,","DOI":"10.3390\/jof9080800","article-title":"Anti-candidal marine natural products: a review","volume":"9","author":"Ganeshkumar","year":"2023","journal-title":"J. Fungi (Basel)"},{"key":"10.1016\/j.heliyon.2024.e35835_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9870679","article-title":"Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi","volume":"2017","author":"Parente-Rocha","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35835_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009711","article-title":"Azole-resistant Aspergillus fumigatus in the environment: identifying key reservoirs and hotspots of antifungal resistance","volume":"17","author":"Burks","year":"2021","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35835_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/jof6040321","article-title":"Amphotericin B and other polyenes-discovery, clinical use, mode of action and drug resistance","volume":"6","author":"Carolus","year":"2021","journal-title":"J. Fungi. (Basel)"},{"key":"10.1016\/j.heliyon.2024.e35835_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.12688\/f1000research.28327.1","article-title":"Novel antifungal agents in clinical trials","volume":"10","author":"Jacobs","year":"2021","journal-title":"F1000 Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35835_bib20","article-title":"Molecular mechanisms governing antifungal drug resistance","volume":"1","author":"Lee","year":"2023","journal-title":"NPJ. Antimicrob. Resist."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib21","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","article-title":"Echinocandins \u2013 structure, mechanism of action and use in antifungal therapy","volume":"37","author":"Szyma\u0144ski","year":"2022","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e35835_bib22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/514669","article-title":"Flucytosine immunotherapy for cryptococcosis","volume":"2","author":"Hospenthal","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e35835_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/528521","article-title":"Fungal biofilm resistance","volume":"2012","author":"Ramage","year":"2012","journal-title":"Int. J. Microbiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35835_bib24","article-title":"The future of antifungal drug therapy: novel compounds and targets","volume":"65","author":"Fernandes","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35835_bib25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.12688\/f1000research.25424.1","article-title":"Advances in understanding the evolution of fungal genome architecture","volume":"27","author":"Priest","year":"2020","journal-title":"F1000 Res"},{"issue":"22","key":"10.1016\/j.heliyon.2024.e35835_bib26","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.3390\/molecules26227061","article-title":"Drug Design: where we are and future prospects","volume":"26","author":"Zagotto","year":"2002","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35835_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/ijms19030909","article-title":"Amino acid metabolism and transport mechanisms as potential antifungal targets","volume":"19","author":"McCarthy","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35835_bib28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/jof9080800","article-title":"Anti-candidal marine natural products: a review","volume":"9","author":"Ganeshkumar","year":"2023","journal-title":"J. Fungi"},{"key":"10.1016\/j.heliyon.2024.e35835_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmicb.2020.00296","article-title":"Potential antifungal targets based on glucose metabolism pathways of Candida albicans","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Microbiol."},{"issue":"39","key":"10.1016\/j.heliyon.2024.e35835_bib30","doi-asserted-by":"crossref","first-page":"40852","DOI":"10.1074\/jbc.M400216200","article-title":"The ATC1 gene encodes a cell wall-linked acid trehalase required for growth on trehalose in Candida albicans","volume":"279","author":"Pedre\u00f1o","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/21505594.2020.1748930","article-title":"The regulation of hyphae growth in Candida albicans","volume":"11","author":"Chena","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.heliyon.2024.e35835_bib32","article-title":"Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites\u2014perspectives for its use as a therapeutic target","volume":"2011","author":"Avil\u00e1n","year":"2011","journal-title":"Enz. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35835_bib33","doi-asserted-by":"crossref","first-page":"10.1128","DOI":"10.1128\/microbiolspec.FUNK-0035-2016","article-title":"The fungal cell wall: structure, biosynthesis, and function","volume":"5","author":"Gow","year":"2017","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35835_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00053-16","article-title":"Central role of the trehalose biosynthesis pathway in the pathogenesis of human fungal infections: opportunities and challenges for therapeutic development","volume":"81","author":"Thammahong","year":"2017","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35835_bib35","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.3390\/ijms10093793","article-title":"Trehalose metabolism: from osmoprotection to signaling","volume":"10","author":"Iturriaga","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e35835_bib36","first-page":"12","article-title":"Influence of pathogen carbon metabolism on interactions with host immunity","author":"Berguson","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41430-021-00943-0","article-title":"Amino acid metabolism and signalling pathways: potential targets in the control of infection and immunity","volume":"75","author":"Tom\u00e9","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35835_bib38","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.3390\/molecules18078200","article-title":"Advances in fruit aroma, volatile research","volume":"18","author":"Hadi","year":"2013","journal-title":"Mol"},{"issue":"44","key":"10.1016\/j.heliyon.2024.e35835_bib39","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1021\/acs.biochem.7b00849","article-title":"Bacterial branched-chain amino acid biosynthesis: structures, mechanisms, and drug ability","volume":"56","author":"Tathyana","year":"2017","journal-title":"Biochem"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35835_bib40","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/ph14121312","article-title":"Advances in antifungal drug development: an up-to-date mini review","volume":"14","author":"Bouz","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.heliyon.2024.e35835_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9870679","article-title":"Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi","volume":"2017","author":"Parente-Rocha","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35835_bib42","article-title":"Beyond ergosterol: strategies for combatting antifungal resistance in Aspergillus fumigatus and Candida auris","volume":"133","author":"Cruz","year":"2023","journal-title":"Tetrahedron"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35835_bib43","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/ph14121312","article-title":"Advances in antifungal drug development: an up-to-date mini review","volume":"14","author":"Bouz","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35835_bib44","first-page":"B5288","article-title":"Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment","volume":"63","author":"Jensen","year":"2016","journal-title":"Dan Med J"},{"key":"10.1016\/j.heliyon.2024.e35835_bib45","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopha.2018.12.009","article-title":"Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases","volume":"110","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e35835_bib46","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/504491","article-title":"Contemporary tools for the diagnosis and management of invasive mycoses","volume":"43","author":"Alexande","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35835_bib47","article-title":"Cutaneous fungal infections in patients experiencing homelessness and treatment in low-resource settings: a scoping review","volume":"14","author":"Rasul","year":"2022","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35835_bib48","first-page":"718","article-title":"Saccharomyces cerevisiae-based probiotics as novel antimicrobial agents to prevent and treat vaginal infections","volume":"21","author":"Gaziano","year":"2017","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib49","first-page":"20","article-title":"Invasive candidiasis","volume":"10","author":"Lass-Fl\u00f6rl","year":"2024","journal-title":"Nat. Rev. Dis."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35835_bib50","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/JCM.40.8.2860-2865.2002","article-title":"Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR","volume":"40","author":"Luo","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/labmed\/15.2.109","article-title":"Use of calcofluor white in clinical mycology","volume":"5","author":"Hageage","year":"1984","journal-title":"Lab. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/clinids\/14.Supplement_1.S23","article-title":"Laboratory methods for the diagnosis and confirmation of systemic mycoses","volume":"14","author":"Kaufman","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35835_bib53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0891-5520(05)70184-7","article-title":"Laboratory diagnosis of bacteremia and fungemia","volume":"15","author":"Magadia","year":"2001","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.heliyon.2024.e35835_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0272-2712(18)30396-2","article-title":"Laboratory detection of fungemia","volume":"14","author":"Geha","year":"1994","journal-title":"Clin. Lab. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35835_bib55","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/CMR.10.3.444","article-title":"Update on detection of bacteremia and fungemia","volume":"10","author":"Reimer","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35835_bib56","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/JCM.36.5.1176-1179.1998","article-title":"Evaluation of BACTEC MYCO\/Flytic medium for recovery of mycobacteria and fungi from blood","volume":"36","author":"Waite","year":"1998","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35835_bib57","first-page":"642","article-title":"Management of mycoses in daily practice, G. Ital","volume":"152","author":"Drago","year":"2017","journal-title":"Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35835_bib58","first-page":"53","article-title":"Clinical evaluation of a topical formulation for the management of onychomycosis","volume":"13","author":"Maggioni","year":"2020","journal-title":"J. Clin. Aesthet. Dermatol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35835_bib59","first-page":"5","article-title":"Tineacorporis: an updated review","volume":"20","author":"Leung","year":"2020","journal-title":"Drugs Context"},{"key":"10.1016\/j.heliyon.2024.e35835_bib60","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/infdis\/153.5.933","article-title":"Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils","volume":"153","author":"Frey","year":"1986","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e35835_bib61","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e35835_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-0-387-34814-8_8","article-title":"Regulation of adaptive immunity by cells of the innate immune system: bone marrow natural killer cells inhibit T cell proliferation","volume":"590","author":"Trivedi","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35835_bib63","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35835_bib64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/biomed2020017","article-title":"Comprehensive review on the management of COVID-19-associated mucormycosis (CAM): the new basics","volume":"2","author":"Girdhar","year":"2022","journal-title":"BioMed"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e35835_bib65","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.3390\/jcm11133620","article-title":"Current treatment options for COVID-19 associated mucormycosis: present status and future perspectives","volume":"11","author":"Madhavan","year":"2022","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35835_bib66","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S1473-3099(22)00124-4","article-title":"Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: delphi consensus statement from the fungal infection study forum and academy of pulmonary sciences, India","volume":"22","author":"Muthu","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e35835_bib67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s15010-022-01891-y","article-title":"MuCOVIDYH group, COVID-19 associated multi systemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome","volume":"51","author":"Sahu","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.heliyon.2024.e35835_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9509705","article-title":"Clinicomycological characterization of superficial mycoses from a tertiary care hospital in Nepal","volume":"2016","author":"Khadka","year":"2016","journal-title":"Dermatol. Res. Pract."},{"key":"10.1016\/j.heliyon.2024.e35835_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1135541","article-title":"Immunotherapies against human bacterial and fungal infectious diseases: a review","volume":"10","author":"Qadri","year":"2023","journal-title":"Front. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35835_bib70","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.vaccine.2013.01.025","article-title":"Monoclonal antibodies for prophylactic and therapeutic use against viral infections","volume":"31","author":"Both","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/jof6010031","article-title":"Immunotherapy against systemic fungal infections based on monoclonal antibodies","volume":"6","author":"Boniche","year":"2020","journal-title":"J. Fungi"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CMR.12.1.19","article-title":"Role of heat shock proteins in protection from and pathogenesis of infectious diseases","volume":"12","author":"Z\u00fcgel","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2217\/imt.09.43","article-title":"Directing dendritic cell immunotherapy towards successful cancer treatment","volume":"2","author":"Sabado","year":"2010","journal-title":"Immunothrapy"},{"key":"10.1016\/j.heliyon.2024.e35835_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1752-0509-4-137","article-title":"Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase","volume":"4","author":"Patil","year":"2010","journal-title":"BMC Syst. Biol."},{"issue":"7161","key":"10.1016\/j.heliyon.2024.e35835_bib75","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35835_bib76","doi-asserted-by":"crossref","first-page":"a019711","DOI":"10.1101\/cshperspect.a019711","article-title":"Fungal vaccines and immunotherapeutics","volume":"4","author":"Santos","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"52","key":"10.1016\/j.heliyon.2024.e35835_bib77","doi-asserted-by":"crossref","first-page":"90521","DOI":"10.18632\/oncotarget.19361","article-title":"Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities","volume":"8","author":"Xia","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e35835_bib78","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3389\/fimmu.2019.02711","article-title":"CAR T cells beyond cancer: hope for immunomodulatory therapy of infectious diseases","volume":"10","author":"Seif","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib79","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s43018-021-00244-2","article-title":"Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors","volume":"2","author":"Hirabayashi","year":"2021","journal-title":"Nat. Cancer."},{"key":"10.1016\/j.heliyon.2024.e35835_bib80","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMp2029466","article-title":"Vaccine innovations \u2014 past and future","volume":"384","author":"Gerberding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"33","key":"10.1016\/j.heliyon.2024.e35835_bib81","article-title":"Vaccines for human fungal diseases: close but still a long way to go","volume":"6","author":"Oliveira","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.heliyon.2024.e35835_bib82","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fmicb.2011.00171","article-title":"Fungal polysaccharides: biological activity beyond the usual structural properties","volume":"2","author":"Rodrigues","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib83","article-title":"Th17 cells and inflammation in neurological disorders: possible mechanisms of action","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.12688\/f1000research.13020.1","article-title":"Update on regulation and effector functions of Th17 cells","volume":"7","author":"Sandquist","year":"2018","journal-title":"F1000 Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35835_bib85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/jof6030119","article-title":"Advances in fungal peptide vaccines","volume":"6","author":"Da Silva","year":"2020","journal-title":"J. Fungi"},{"key":"10.1016\/j.heliyon.2024.e35835_bib86","first-page":"283","article-title":"Vaccine adjuvants: mechanisms and platforms, Signal transduction and targeted therapy","volume":"8","author":"Zhao","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35835_bib87","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/pharmaceutics14081671","article-title":"Protein-based adjuvants for vaccines as immunomodulators of the innate and adaptive immune response: current knowledge, challenges, and future opportunities","volume":"14","author":"D\u00edaz-Dinamarca","year":"2022","journal-title":"Pharmaceutics"},{"issue":"52","key":"10.1016\/j.heliyon.2024.e35835_bib88","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"issue":"6194","key":"10.1016\/j.heliyon.2024.e35835_bib89","article-title":"NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice","volume":"9","author":"Alqarihi","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib90","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41479-022-00097-y","article-title":"The remarkable history of pneumococcal vaccination: an ongoing challenge","volume":"14","author":"Musher","year":"2022","journal-title":"Pneumonia"},{"key":"10.1016\/j.heliyon.2024.e35835_bib91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1126\/sciadv.abk3150","article-title":"Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine","volume":"8","author":"Smith","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.heliyon.2024.e35835_bib92","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/vaccines10081367","article-title":"Current vaccine platforms in enhancing T-Cell Response","volume":"8","author":"Ura","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.heliyon.2024.e35835_bib94","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.R120.002309","article-title":"The peptide vaccine of the future","volume":"20","author":"Nelde","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"issue":"4538","key":"10.1016\/j.heliyon.2024.e35835_bib95","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.215.4538.1346.c","article-title":"Synthetic vaccines","volume":"215","author":"Langbeheim","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e35835_bib96","first-page":"229","article-title":"Peptides as active probes","volume":"73","author":"Und\u00e9n","year":"1995","journal-title":"EXS"},{"issue":"17","key":"10.1016\/j.heliyon.2024.e35835_bib97","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e35835_bib98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2601(08)60212-9","article-title":"Recent research on selective exposure to information","volume":"19","author":"Frey","year":"1986","journal-title":"Adv. Exp. Social Psychol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35835_bib99","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.21786\/bbrc\/14.4.9","article-title":"An updated review on nanomaterials for biomedical advancements: concepts and applications","volume":"14","author":"Adhikary","year":"2021","journal-title":"Biosci. Biotechnol. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e35835_bib100","series-title":"W. Viral, Parasitic, Bacterial, and Fungal Infections (314-358)","article-title":"Malaria: epidemiology, pathogenesis and therapeutics","author":"Adhikary","year":"2022"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35835_bib101","first-page":"183","article-title":"Nutritional aspects, chemistry profile, extraction techniques of lemongrass essential oil and it's physiological benefits","volume":"43","author":"Adhikary","year":"2024","journal-title":"J. Am. Nutr. Assoc."},{"key":"10.1016\/j.heliyon.2024.e35835_bib102","doi-asserted-by":"crossref","DOI":"10.1515\/bmc-2022-0042","article-title":"\u03b2-Amyloid peptide modulates peripheral immune responses and neuroinflammation in rats","volume":"15","author":"Adhikary","year":"2024","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.heliyon.2024.e35835_bib103","series-title":"Parasitic, Bacterial, and Fungal Infections (314-358)","article-title":"Prion diseases: a rare group of neurodegenerative disorders","author":"Banerjee","year":"2022"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35835_bib104","first-page":"1505","article-title":"Natural antioxidants and nutraceuticals to fight against common human diseases: an overview","volume":"12","author":"Chowdhury","year":"2023","journal-title":"Euro. Chem. Bull."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35835_bib105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.62110\/sciencein.cbl.2024.v11.659","article-title":"Exploring small-molecule inhibitors targeting MAPK pathway components: focus on ERK, MEK1, and MEK2 kinases in cancer treatment","volume":"11","author":"Mukherjee","year":"2004","journal-title":"Chemical Biol. Letter"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35835_bib106","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/15376520590968824","article-title":"Induction of oxidative stress on reproductive and metabolic organs in sodium fluoride treated male albino rats: protective effect of testosterone and vitamin-E co-administration","volume":"15","author":"Das (Sarkar)","year":"2005","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.heliyon.2024.e35835_bib107","series-title":"Nutrition and Functional Foods in Boosting Digestion, Metabolism and Immune Health","first-page":"123","article-title":"Digestion and gut microbiome","author":"Banerjee","year":"2021"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35835_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.imj.2024.100112","article-title":"Mucormycosis during COVID-19 era: a retrospective assessment","volume":"3","author":"Mukherjee","year":"2004","journal-title":"Infect. Med."},{"key":"10.1016\/j.heliyon.2024.e35835_bib109","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1128\/IAI.70.7.3759-3767.2002","article-title":"Cellular and molecular regulation of vaccination with heat shock protein 60 from histoplasma capsulatum","volume":"70","author":"Deepe","year":"2002","journal-title":"Infect. Immun."},{"issue":"52","key":"10.1016\/j.heliyon.2024.e35835_bib110","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35835_bib111","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14787210.2020.1792288","article-title":"Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies","volume":"18","author":"Fernandes","year":"2020","journal-title":"Expert. Rev. Anti Infect. Ther."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35835_bib112","doi-asserted-by":"crossref","first-page":"e00070","DOI":"10.1128\/IAI.00070-18","article-title":"Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (RCpa1) against pulmonary Coccidioides posadasii infection","volume":"86","author":"Hung","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.heliyon.2024.e35835_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868523","article-title":"Three models of vaccination strategies against cryptococcosis in immunocompromised hosts using heat-killed Cryptococcus neoformans \u0394sgl1","volume":"13","author":"Normile","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35835_bib114","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02785-21","article-title":"Immunoprotection against cryptococcosis offered by Znf2 depends on capsule and the hyphal morphology","volume":"13","author":"Lin","year":"2022","journal-title":"mBio"},{"issue":"30","key":"10.1016\/j.heliyon.2024.e35835_bib115","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.vaccine.2021.06.001","article-title":"Synthetic conjugate peptide Fba-Met6 (MP12) induces complement mediated resistance against disseminated Candida albicans","volume":"39","author":"Adams","year":"2021","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35835_bib116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/pnasnexus\/pgac248","article-title":"Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis","volume":"1","author":"Rayens","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.heliyon.2024.e35835_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.863234","article-title":"Immunoinformatic design of a multivalent peptide vaccine against mucormycosis: targeting FTR1 protein of major causative fungi","volume":"13","author":"Araf","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib118","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13238","article-title":"Protective effect of fungal extracellular vesicles against murine candidiasis","volume":"22","author":"Vargas","year":"2020","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib119","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00253-021-11114-3","article-title":"Host defence peptides identified in human apolipoprotein B as promising antifungal agents","volume":"105","author":"Dellolmo","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e35835_bib120","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","author":"Hoekstra","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35835_bib121","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/AAC.03707-14","article-title":"The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme","volume":"58","author":"Warrilow","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2024.e35835_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000133","article-title":"Antifungal activity of Allamanda polyantha seed extract and its iridoids promote morphological alterations in Cryptococcus spp","volume":"353","author":"Bresciani","year":"2020","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.heliyon.2024.e35835_bib123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11274-017-2214-9","article-title":"\u03b1-Bisabolol inhibits Aspergillus fumigatus Af239 growth via affecting microsomal \u039424-sterol methyltransferase as a crucial enzyme in ergosterol biosynthesis pathway","volume":"33","author":"Jahanshiri","year":"2017","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e35835_bib124","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1093\/infdis\/jix130","article-title":"Novel agents and drug targets to meet the challenges of resistant fungi","volume":"216","author":"McCarthy","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35835_bib125","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.4049\/jimmunol.1001725","article-title":"Granulysin production and anticryptococcal activity is dependent upon a far upstream enhancer that binds STAT5 in human peripheral blood CD4+ T cells","volume":"185","author":"Xing","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35835_bib126","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI41963","article-title":"Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain","volume":"120","author":"Shi","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35835_bib127","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1128\/IAI.01232-08","article-title":"Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity","volume":"77","author":"Marr","year":"2007","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35835_bib128","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.4049\/jimmunol.180.11.7221","article-title":"Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients","volume":"180","author":"Zheng","year":"2008","journal-title":"J. Immuno."},{"key":"10.1016\/j.heliyon.2024.e35835_bib129","first-page":"283","article-title":"HLA antigen frequencies in familial Crohn's disease (CD)","volume":"26","author":"K\u00fchnl","year":"1990","journal-title":"Beitr. Infusionsther."}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2024.e35835","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000}},{"DOI":"10.1016\/j.heliyon.2024.e41363","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000}},{"DOI":"10.1016\/j.heliyon.2024.e41363","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"record-id":"72380"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402411866X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402411866X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:08:51Z","timestamp":1773184131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402411866X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":129,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S240584402411866X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35835","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Novel targets and improved immunotherapeutic techniques with an emphasis on antimycosal drug resistance for the treatment and management of mycosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"e35835"}}